A total of @ patients with successful drug-eluting stent ( DES ) implantation were randomly assigned to dual antiplatelet therapy ( DAT ; aspirin and clopidogrel , n = @ ) or to triple antiplatelet therapy ( TAT ; DAT with cilostazol , n = @ ) .